Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. (Q51545663)
Jump to navigation
Jump to search
scientific article published on 26 August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. |
scientific article published on 26 August 2010 |
Statements
1 reference
Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. (English)
1 reference
Masafumi Kobayashi
1 reference
Yuko Takahashi
1 reference
Hiroyuki Yamashita
1 reference
Hiroshi Kaneko
1 reference
Akio Mimori
1 reference
26 August 2010
1 reference
21
1 reference
1
1 reference
92-96
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference